Alexander KarpAlexander Karp earned $1B in 2024

In 2023, David Stack earned $2.64M in total compensation at Pacira BioSciences, Inc., including $941.39K salary, $720.60K bonus and $934.47K in stock. Most recently acquired 32,700 shares in Jun 2023. Currently holds stock worth $6.88M. Has donated $145.86K in stock to charitable causes. Led Pacira BioSciences, Inc. as CEO for 13 years.

Compensation History

Annual executive compensation data for David Stack, including salary, bonuses, and stock awards.

Year

2023

Total Compensation

$2.64M

Salary

$941.39K

Bonus

$720.60K

Other

$39.52K

Salary

$941.39K

Board Justification

The compensation program aims to attract, retain, and motivate executives, aligning their interests with those of stockholders through performance-based incentives.

Bonus

$720.60K

Board Justification

Annual incentive payment of 90% of target based on operational and financial performance for 2023.

Other Compensation

$39.52K

Board Justification

Includes health, dental, vision, disability, and group term life insurance premiums paid by the company.

Restricted Stock

$934.47K24.08K RSU

Board Justification

24,075 shares of RSUs vested in 2023, valued at $934,470.

Performance Metrics

Performance metrics include operational and financial goals, with a focus on net product sales and adjusted EBITDA.

P

David Stack

Ex-CEO of Pacira BioSciences, Inc.

Education

Bachelor's degree in Business Administration

Field of Expertise

Healthcare & Life Sciences - Pharmaceuticals

Sector of Economy

Healthcare

Born

January 1, 1962 - 63 years ago

CEO of Pacira BioSciences, Inc. for

13 years 2 months (Oct 2010 - Dec 2023)

Previous Experience

Chief Executive Officer of Pacira Pharmaceuticals, Inc. since 2010; previously held senior leadership roles at various pharmaceutical companies.

Holdings

Track David Stack's stock holdings and portfolio value over time.

Total Stock Sold

$47.85M

PCRX

$47.85M

900,290 PCRX shares

What if they kept their stock?

If David Stack didn't sell their stock, today they would have:
Extra PCRX900,290 shares worth $21.60M.
This is -54.87% and $26.25M less than what they got when they sold the stock.

Charitable Transactions

PCRX

6,080 shares

PCRX

Recent Charitable Transactions

PCRX

1,080 shares

PCRX

Mar 24, 2021

Charity

PCRX

2,000 shares

PCRX

Dec 31, 2013

Charity

PCRX

3,000 shares

PCRX

Dec 31, 2011

Charity

Insider Trading

David Stack's recent stock transactions, purchases, and sales filed with the SEC.

PCRX

32,700 shares

PCRX

Jun 14, 2023

Received

PCRX

$399.04K

PCRX at $38.43/share

Jun 6, 2023

Sale

PCRX

$1.57M

PCRX at $60.81/share

Jun 6, 2022

Sale

PCRX

21,500 shares

PCRX

Jun 6, 2022

Received

PCRX

17,800 shares

PCRX

Jun 9, 2021

Received

PCRX

$909.76K

PCRX at $61.04/share

Jun 4, 2021

Sale

PCRX

$2.61M

PCRX at $61.44/share

Mar 24, 2021

Sale

PCRX

1,080 shares

PCRX

Mar 24, 2021

Charity

PCRX

$2.98M

PCRX at $70.04/share

Feb 2, 2021

Sale

PCRX

$4.98M

PCRX at $55.36/share

Oct 14, 2020

Sale

Rivals

Compare David Stack with competitor CEOs and industry peers.